RSV Vaccine
Study background
This is a research study looking into an investigational vaccine for respiratory syncytial virus (RSV) that involves people 60 years of age and older. RSV is a common virus that usually produces mild, cold-like symptoms. Whilst recovery can be quick, RSV is becoming increasingly recognized as a major cause of serious illness in older adults.
Recent studies have shown that RSV infection develops in up to 10 percent of high-risked individuals and in 7 percent of healthy adults. There is no vaccine on the market that is currently available to protect against RSV.
Study Details
The study would require you to come to the clinic 3 times over 1 month and then a visit every 6 months for 2 years. Visits will range between 15 minutes to an hour each time you come in. Over the course of the study, we will check your medical history, take your bloods and administer the investigational vaccine or placebo. You will also need to complete an e-diary over the course of the study recording any symptoms you may experience.
You will be reimbursed for your time and involvement in the research study.
Eligibility criteria
- 60 years of age and older
- Is not immunocompromised